Antibody therapies for treatment of non-severe COVID-19. | Intern Emerg Med;17(3): 883-885, 2022 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Antibody therapies for treatment of non-severe COVID-19.

Gourlay, Katie; Taylor, Nicholas; Lang, Eddy.

Gourlay K; Faculty of Medicine, The University of Alberta, Edmonton, AB, Canada. gourlay@ualberta.ca.
Taylor N; Faculty of Medicine, The University of Alberta, Edmonton, AB, Canada.
Lang E; Department of Emergency Medicine, The University of Calgary, Calgary, AB, Canada.

Intern Emerg Med ; 17(3): 883-885, 2022 04.

Article in English | MEDLINE | ID: covidwho-1748432

Subject(s)

COVID-19 Drug Treatment; Antibodies, Viral; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2022 Document Type: Article Affiliation country: S11739-022-02959-1

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Intern Emerg Med Journal subject: Emergency Medicine / Internal Medicine Year: 2022 Document Type: Article Affiliation country: S11739-022-02959-1